News
For cell and gene therapy, a consistent supply of quality starting material is vital that is maintained throughout the ...
Out of the shadows, new CDMO Artis BioSolutions has decloaked on a mission to tackle the tricky production process for ...
Cell- and gene-therapy-focused ElevateBio has let go of 17% of staffers as part of the company’s second layoff round since ...
Here is our list of the 11 Best Gene Therapy Stocks to Buy According to Analysts.
21d
MyChesCo on MSNChromaTan and Landmark Bio Receive NIIMBL Grant to Advance AAV Gene Therapy ManufacturingThe grant will enable the two organizations to create an accessible, cost-effective manufacturing platform for AAV-based gene ...
A little over a year after winning manufacturing certification for its cell therapy factory-in-a-box, South San Francisco’s ...
The biopharmaceutical landscape stands at the cusp of a transformative era, with artificial intelligence (AI) leading the charge. For gene therapy developers, every key milestone significantly ...
A £13 million funding boost has been announced to support 14 pioneering projects aimed at reshaping how medicines are made in ...
Landmark Bio acquired by Artis BioSolutions to expand manufacturing and commercialization of advanced therapies: Watertown, Massachusetts Thursday, April 3, 2025, 14:00 Hrs [IST] ...
None of the cell and gene therapies that reached the final regulatory submission stage were rejected by the FDA.
Artis BioSolutions, founded to streamline the discovery, development & production of genetic medicines, has launched and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results